I agree that this site is using cookies. You can find further informations here.
X
Kumagai, Yuji
468  results:
Search for persons X
?
1

Persistence of immune responses of a self-amplifying RNA CO..:

Oda, Yoshiaki ; Kumagai, Yuji ; Kanai, Manabu...
The Lancet Infectious Diseases.  24 (2024)  4 - p. 341-343 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Immunogenicity and safety of a booster dose of a self-ampli..:

Oda, Yoshiaki ; Kumagai, Yuji ; Kanai, Manabu...
The Lancet Infectious Diseases.  24 (2024)  4 - p. 351-360 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Efficacy and safety of single-dose ivermectin in mild-to-mo..:

Wada, Tatsuhiko ; Hibino, Makoto ; Aono, Hiromi...
Frontiers in Medicine.  10 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
4

Pharmacokinetics of low doses of colchicine in the leukocyt..:

Mutoh, Akiko ; Uehara, Hitoshi ; Maeda, Asano...
Translational and Clinical Pharmacology.  31 (2023)  4 - p. 217 , 2023
Link: https://doi.org/10.12793..
 
?
5

Real‐World Hepatic Safety of Oral Acetaminophen Versus Loxo..:

Okumura, Yasuyuki ; Kimura, Takeshi ; Inokuchi, Shoichiro...
The Journal of Clinical Pharmacology.  63 (2023)  7 - p. 798-806 , 2023
Link: https://doi.org/10.1002/..
 
?
6

Pharmacokinetics, Safety, and Tolerability of Single and Mu..:

Shirae, Shinichiro ; Ose, Atsushi ; Kumagai, Yuji
Clinical Pharmacology in Drug Development.  11 (2022)  6 - p. 744-753 , 2022
Link: https://doi.org/10.1002/..
 
?
7

Effects of Low-Dose Colchicine on Serum High-Sensitivity C-..:

Miwa, Yoshikazu ; Mutoh, Akiko ; Morimoto, Takeshi...
Biomedicine Hub.  7 (2022)  3 - p. 156-164 , 2022
Link: https://doi.org/10.1159/..
 
?
8

Phase 1 Clinical Trial of PPMX‐T003, a Novel Human Monoclon..:

Ogama, Yoichiro ; Kumagai, Yuji ; Komatsu, Norio...
Clinical Pharmacology in Drug Development.  12 (2022)  6 - p. 579-587 , 2022
Link: https://doi.org/10.1002/..
 
?
9

Mammaglobin 1 mediates progression of trastuzumab‐resistant..:

Kusumastuti, Ratih ; Kumagai, Yuji ; Ishihara, Seiichiro...
FEBS Open Bio.  12 (2022)  10 - p. 1797-1813 , 2022
Link: https://doi.org/10.1002/..
 
?
10

Appraisal of ICH E14/S7B Q&As adopted in February 2022 usin..:

Kambayashi, Ryuichi ; Goto, Ai ; Izumi-Nakaseko, Hiroko...
Journal of Pharmacological Sciences.  150 (2022)  3 - p. 191-199 , 2022
Link: https://doi.org/10.1016/..
 
?
11

The interferon-β/STAT1 axis drives the collective invasion ..:

Kumagai, Yuji ; Nio-Kobayashi, Junko ; Ishihara, Seiichiro...
Oncogenesis.  11 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
12

Concentration–QTc analysis for single arm studies:

Orihashi, Yasushi ; Ohwada, Shoichi ; Kumagai, Yuji
Journal of Pharmacokinetics and Pharmacodynamics.  48 (2021)  2 - p. 203-211 , 2021
Link: https://doi.org/10.1007/..
 
?
13

The necessary conduct: Exploratory multiregional clinical t..:

Jeon, Inseung ; Kim, Yu Kyong ; Song, Ildae...
Clinical and Translational Science.  14 (2021)  6 - p. 2399-2407 , 2021
Link: https://doi.org/10.1111/..
 
?
14

Real‐world evidence of population differences in allopurino..:

Sato, Tsugumichi ; Cheng, Ching‐Lan ; Park, Heung‐Woo...
Clinical and Translational Science.  14 (2021)  3 - p. 1002-1014 , 2021
Link: https://doi.org/10.1111/..
 
?
15

Concentration-QTc analysis with two or more correlated base..:

Orihashi, Yasushi ; Kumagai, Yuji
Journal of Pharmacokinetics and Pharmacodynamics.  48 (2021)  5 - p. 615-622 , 2021
Link: https://doi.org/10.1007/..
 
1-15